The effect of locally delivered recombinant human bone morphogenetic protein-2 with hydroxyapatite/tri-calcium phosphate on the biomechanical properties of bone in diabetes-related osteoporosis

Journal of Orthopaedics and Traumatology

Volumn 16, Issue 2, 2015, Pages 151-159

  Liporace, Frank A ^a   Breitbart, Eric A ^b   Yoon, Richard S ^a   Doyle, Erin ^b   Paglia, David N ^b   Lin, Sheldon ^b  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Calcium phosphate; Diabetes; Fracture; Hydroxyapatite; Osteoporosis; rhBMP 2

Indexed keywords

CALCIUM PHOSPHATE; HYDROXYAPATITE; INSULIN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE DEVELOPMENT; BONE RADIOGRAPHY; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN DEPENDENT DIABETES MELLITUS RELATED OSTEOPOROSIS; INSULIN RELEASE; LOW DRUG DOSE; MALE; MECHANICAL TORSION; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSTEOPOROSIS; PARTICLE SIZE; PHYSICAL PARAMETERS; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RAT; SHEAR MODULUS; SHEAR STRESS; TORQUE TO FAILURE; ANIMAL; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; FEMUR; PATHOLOGY; WISTAR RAT;

ANIMALS; BIOMECHANICAL PHENOMENA; BONE DENSITY; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATES; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; DURAPATITE; FEMUR; MALE; OSTEOGENESIS; OSTEOPOROSIS; RATS, WISTAR; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA; X-RAY MICROTOMOGRAPHY;

EID: 84929712540     PISSN: 15909921     EISSN: 15909999     Source Type: Journal    
DOI: 10.1007/s10195-014-0327-6     Document Type: Article

References (36)

1. McCabe LR (2007) Understanding the pathology and mechanisms of type I diabetic bone loss. J Cell Biochem 102(6):1343–1357. doi:10.1002/jcb.21573
2. Schneider LE, Schedl HP (1972) Diabetes and intestinal calcium absorption in the rat. Am J Physiol 223(6):1319–1323
3. Schneider LE, Wilson HD, Schedl HP (1977) Effects of diabetes and vitamin D-depletion on duodenal and ileal calcium transport in the rat. Acta Diabetol Lat 14(1–2):18–25
4. Weintroub S, Cohen DF, Salama R, Streifler M, Weissman SL (1980) Skeletal findings in human neutrolethyrism. Is there a human osteolathyrism? Eur Neurol 19(2):121–127
5. Kim SE, Jeon O, Lee JB, Bae MS, Chun HJ, Moon SH, Kwon IK (2008) Enhancement of ectopic bone formation by bone morphogenetic protein-2 delivery using heparin-conjugated PLGA nanoparticles with transplantation of bone marrow-derived mesenchymal stem cells. J Biomed Sci 15(6):771–777. doi:10.1007/s11373-008-9277-4
6. Wu X, Shi W, Cao X (2007) Multiplicity of BMP signaling in skeletal development. Ann N Y Acad Sci 1116:29–49. doi:10.1196/annals.1402.053
7. Garimella R, Tague SE, Zhang J, Belibi F, Nahar N, Sun BH, Insogna K, Wang J, Anderson HC (2008) Expression and synthesis of bone morphogenetic proteins by osteoclasts: a possible path to anabolic bone remodeling. J Histochem Cytochem 56(6):569–577. doi:10.1369/jhc.2008.950394
8. Zhao GQ (2003) Consequences of knocking out BMP signaling in the mouse. Genesis 35(1):43–56. doi:10.1002/gene.10167
9. Wan M, Cao X (2005) BMP signaling in skeletal development. Biochem Biophys Res Commun 328(3):651–657. doi:10.1016/j.bbrc.2004.11.067
10. Wang Y, Nishida S, Elalieh HZ, Long RK, Halloran BP, Bikle DD (2006) Role of IGF-I signaling in regulating osteoclastogenesis. J Bone Miner Res 21(9):1350–1358. doi:10.1359/jbmr.060610
11. Ishidou Y, Kitajima I, Obama H, Maruyama I, Murata F, Imamura T, Yamada N, ten Dijke P, Miyazono K, Sakou T (1995) Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation. J Bone Miner Res 10(11):1651–1659. doi:10.1002/jbmr.5650101107
12. Zhang F, Qiu T, Wu X, Wan C, Shi W, Wang Y, Chen J, Wan M, Clemens TL, Cao X (2009) Sustained BMP signaling in osteoblasts stimulates bone formation by promoting angiogenesis and osteoblast differentiation. J Bone Miner Res. doi:10.1359/jbmr.090204
13. Autefage H, Briand-Mesange F, Cazalbou S, Drouet C, Fourmy D, Goncalves S, Salles JP, Combes C, Swider P, Rey C (2009) Adsorption and release of BMP-2 on nanocrystalline apatite-coated and uncoated hydroxyapatite/beta-tricalcium phosphate porous ceramics. J Biomed Mater Res B Appl Biomater 91(2):706–715. doi:10.1002/jbm.b.31447
14. Hannink G, Geutjes PJ, Daamen WF, Buma P (2013) Evaluation of collagen/heparin coated TCP/HA granules for long-term delivery of BMP-2. J Mater Sci Mater Med 24(2):325–332. doi:10.1007/s10856-012-4802-4
15. Hulsart-Billstrom G, Hu Q, Bergman K, Jonsson KB, Aberg J, Tang R, Larsson S, Hilborn J (2011) Calcium phosphates compounds in conjunction with hydrogel as carrier for BMP-2: a study on ectopic bone formation in rats. Acta Biomater 7(8):3042–3049. doi:10.1016/j.actbio.2011.04.021
16. Overman JR, Farre-Guasch E, Helder MN, ten Bruggenkate CM, Schulten EA, Klein-Nulend J (2013) Short (15 minutes) bone morphogenetic protein-2 treatment stimulates osteogenic differentiation of human adipose stem cells seeded on calcium phosphate scaffolds in vitro. Tissue Eng Part A 19(3–4):571–581. doi:10.1089/ten.TEA.2012.0133
17. Overman JR, Helder MN, ten Bruggenkate CM, Schulten EA, Klein-Nulend J, Bakker AD (2013) Growth factor gene expression profiles of bone morphogenetic protein-2-treated human adipose stem cells seeded on calcium phosphate scaffolds in vitro. Biochimie 95(12):2304–2313. doi:10.1016/j.biochi.2013.08.034
18. Tazaki J, Murata M, Akazawa T, Yamamoto M, Ito K, Arisue M, Shibata T, Tabata Y (2009) BMP-2 release and dose-response studies in hydroxyapatite and beta-tricalcium phosphate. Bio Med Mater Eng 19(2–3):141–146. doi:10.3233/BME-2009-0573
19. Khosla S, Westendorf JJ, Oursler MJ (2008) Building bone to reverse osteoporosis and repair fractures. J Clin Invest 118(2):421–428. doi:10.1172/JCI33612
20. Marliss EB, Nakhooda AF, Poussier P, Sima AA (1982) The diabetic syndrome of the ‘BB’ Wistar rat: possible relevance to type 1 (insulin-dependent) diabetes in man. Diabetologia 22(4):225–232
21. Verhaeghe J, Visser WJ, Einhorn TA, Bouillon R (1990) Osteoporosis and diabetes: lessons from the diabetic BB rat. Horm Res 34(5–6):245–248
22. Kamiya N (2012) The role of BMPs in bone anabolism and their potential targets SOST and DKK1. Curr Mol Pharmacol 5(2):153–163
23. Beam HA, Parsons JR, Lin SS (2002) The effects of blood glucose control upon fracture healing in the BB Wistar rat with diabetes mellitus. J Orthop Res 20(6):1210–1216. doi:10.1016/S0736-0266(02)00066-9
24. Gooch HL, Hale JE, Fujioka H, Balian G, Hurwitz SR (2000) Alterations of cartilage and collagen expression during fracture healing in experimental diabetes. Connect Tissue Res 41(2):81–91
25. Paglia DN, Wey A, Breitbart EA, Faiwiszewski J, Mehta SK, Al-Zube L, Vaidya S, Cottrell JA, Graves D, Benevenia J, O’Connor JP, Lin SS (2013) Effects of local insulin delivery on subperiosteal angiogenesis and mineralized tissue formation during fracture healing. J Orthop Res 31(5):783–791. doi:10.1002/jor.22288
26. Krishnan V, Ma Y, Moseley J, Geiser A, Friant S, Frolik C (2001) Bone anabolic effects of sonic/indian hedgehog are mediated by bmp-2/4-dependent pathways in the neonatal rat metatarsal model. Endocrinology 142(2):940–947. doi:10.1210/endo.142.2.7922
27. Toth JM, Boden SD, Burkus JK, Badura JM, Peckham SM, McKay WF (2009) Short-term osteoclastic activity induced by locally high concentrations of recombinant human bone morphogenetic protein-2 in a cancellous bone environment. Spine 34(6):539–550. doi:10.1097/BRS.0b013e3181952695
28. Urist MR, Lietze A, Dawson E (1984) Beta-tricalcium phosphate delivery system for bone morphogenetic protein. Clin Orthop Relat Res 187:277–280
29. Urist MR, Nilsson O, Rasmussen J, Hirota W, Lovell T, Schmalzreid T, Finerman GA (1987) Bone regeneration under the influence of a bone morphogenetic protein (BMP) beta tricalcium phosphate (TCP) composite in skull trephine defects in dogs. Clin Orthop Relat Res 214:295–304
30. Alam MI, Asahina I, Ohmamiuda K, Takahashi K, Yokota S, Enomoto S (2001) Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2. Biomaterials 22(12):1643–1651
31. Burg KJ, Porter S, Kellam JF (2000) Biomaterial developments for bone tissue engineering. Biomaterials 21(23):2347–2359
32. Bedi A, Karunakar MA (2006) Physiologic effects of intramedullary reaming. Instr Course Lect 55:359–366
33. Bhandari M, Schemitsch EH (2002) Bone formation following intramedullary femoral reaming is decreased by indomethacin and antibodies to insulin-like growth factors. J Orthop Trauma 16(10):717–722
34. Frolke JP, Nulend JK, Semeins CM, Bakker FC, Patka P, Haarman HJ (2004) Viable osteoblastic potential of cortical reamings from intramedullary nailing. J Orthop Res 22(6):1271–1275. doi:10.1016/j.orthres.2004.03.011
35. Niedziolka J (2000) Intramedullary osteosynthesis for treatment of pseudarthrosis. Chir Narzadow Ruchu Ortop Pol 65(4):427–430
36. Wang CK, Ho ML, Wang GJ, Chang JK, Chen CH, Fu YC, Fu HH (2009) Controlled-release of rhBMP-2 carriers in the regeneration of osteonecrotic bone. Biomaterials. doi:10.1016/j.biomaterials.2009.04.029